We are live on
!
Find out more
EC
EcoR1 Capital Portfolio holdings
AUM
$2.34B
1-Year Est. Return
204.53%
This Fund
S&P 500
This Quarter
Est. Return
+18.8%
1 Year Est. Return
+204.53%
3 Year Est. Return
+306.25%
5 Year Est. Return
+490.45%
10 Year Est. Return
+14,115.48%
AUM
$2.68B
AUM Growth
+$427M
(+19%)
Cap. Flow
+$308M
Cap. Flow
% of AUM
11.53%
Top 10 Holdings %
Top 10 Hldgs %
68.02%
Holding
82
New
12
Increased
16
Reduced
6
Closed
10
Top Buys
| 1 |
Alector
ALEC
|
+$68.6M |
| 2 |
MORF
Morphic Holding, Inc. Common Stock
MORF
|
+$52.4M |
| 3 |
Relay Therapeutics
RLAY
|
+$34.9M |
| 4 |
Arcus Biosciences
RCUS
|
+$32.5M |
| 5 |
Janux Therapeutics
JANX
|
+$31.4M |
Top Sells
| 1 |
Eledon Pharmaceuticals
ELDN
|
+$11.9M |
| 2 |
AMTI
Applied Molecular Transport Inc. Common Stock
AMTI
|
+$10.5M |
| 3 |
Neurogene
NGNE
|
+$8.45M |
| 4 |
AC Immune
ACIU
|
+$6.91M |
| 5 |
KDNY
Chinook Therapeutics, Inc. Common Stock
KDNY
|
+$5.09M |
Sector Composition
| 1 | Healthcare | 98.93% |
| 2 | Financials | 0.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Prothena Corp
PRTA
$447M
| $580M | 21.68% |
11,284,280
+250,000
| +2% | +$7.8M |
|
|
MORF
2
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $227M | 8.48% |
3,951,566
+952,251
| +32% | +$52.4M |
|
3
AnaptysBio
ANAB
$1.65B
| $195M | 7.29% |
7,521,024
+369,400
| +5% | +$8.85M |
|
4
Xencor
XNCR
$1.1B
| $169M | 6.32% |
4,906,106
+5,800
| +0.1% | +$230K |
|
|
5
Relay Therapeutics
RLAY
$4.19B
| $164M | 6.14% |
4,487,776
+1,058,413
| +31% | +$34.9M |
|
6
Nuvation Bio
NUVB
$2.03B
| $128M | 4.77% |
13,711,517
+464,500
| +4% | +$5.3M |
|
7
Shattuck Labs
STTK
$609M
| $96.2M | 3.6% |
3,318,410
+860,151
| +35% | +$25.1M |
|
|
8
Arcus Biosciences
RCUS
$3.52B
| $91.6M | 3.42% |
3,335,247
+1,139,355
| +52% | +$32.5M |
|
|
9
Alector
ALEC
$164M
| $88.4M | 3.3% |
4,242,634
+3,640,034
| +604% | +$68.6M |
|
10
ARS Pharmaceuticals
SPRY
$709M
| $80.9M | 3.02% |
2,618,036
+84,401
| +3% | +$2.71M |
|
11
Kura Oncology
KURA
$998M
| $77.7M | 2.9% |
3,724,437
+31,800
| +0.9% | +$789K |
|
|
MRTX
12
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $75M | 2.8% |
464,298
| – | – |
|
13
Oric Pharmaceuticals
ORIC
$1.14B
| $54.7M | 2.04% |
3,092,218
| – | – |
|
14
Nurix Therapeutics
NRIX
$2.45B
| $52.2M | 1.95% |
1,967,950
-51,069
| -3% | -$1.5M |
|
|
RNAM
15
DELISTED
Avidity Biosciences
RNAM
| $52M | 1.94% |
2,103,950
| – | – |
|
|
16
Janux Therapeutics
JANX
$973M
| $35.2M | 1.32% |
+1,411,975
| New | +$31.4M |
|
17
Solid Biosciences
SLDB
$933M
| $33.7M | 1.26% |
613,513
| – | – |
|
|
GRTS
18
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $31.2M | 1.17% |
3,421,287
| – | – |
|
|
TBIO
19
DELISTED
Translate Bio, Inc. Common Stock
TBIO
| $28.9M | 1.08% |
1,048,976
+452,076
| +76% | +$8.88M |
|
|
ITOS
20
DELISTED
iTeos Therapeutics
ITOS
| $26.6M | 0.99% |
1,035,864
+775,864
| +298% | +$18.5M |
|
21
Edgewise Therapeutics
EWTX
$4.32B
| $26.1M | 0.98% |
1,224,175
| – | – |
|
22
Kymera Therapeutics
KYMR
$9.24B
| $25.2M | 0.94% |
519,416
+419,416
| +419% | +$18.2M |
|
23
Design Therapeutics
DSGN
$833M
| $25.1M | 0.94% |
1,260,019
+122,079
| +11% | +$3.08M |
|
|
AKUS
24
DELISTED
Akouos Inc
AKUS
| $24.8M | 0.93% |
1,975,984
| – | – |
|
25
Arvinas
ARVN
$528M
| $24.8M | 0.93% |
321,724
+3,020
| +0.9% | +$210K |
|
Similar funds
G
MC
BAM
CC
HFM
NO
ST
MFAM